News Headlines
 Journal Headlines

  Site Map
February 14, 2016
About AIDScience
Contact Us

Vol. 3, No. 13, 4 July 2003
Other Issues:

AIDScience Perspectives:
The speed of HIV spread
A study conducted last year by the San Francisco Health Department revealed that approximately 30% of the individuals who recently became HIV positive had used methamphetamine in the last 6 months, adding fuel to the concerned with the association between methamphetamine use and the spread of HIV.

— By Marcia L. Triunfol. 
VaxGen: are there hints of race-based effects?
VaxGen has stood by its statement that their AIDSVAX® vaccine holds promise for a mélange of non-white racial subgroups, a conclusion they said was supported by unreleased data correlating protection in these subgroups with higher antibody levels.
— By Patricia Kahn, from the IAVI Report. 
[About AIDScience articles] [See recent AIDScience articles]
Hot News:
2nd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment (July 13-17, 2003)
Medscape HIV/AIDS is the official provider of online conference coverage and continuing medical education (CME) activities based on the Conference. (Medscape requires one-time free registration)
2nd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment (July 13-17, 2003), as the official webcaster of the IAS conference, will provide webcasts and other resources for all conference plenary sessions and selected additional sessions.
AIDS vaccines: back to 'plan A'
The received wisdom in AIDS vaccine research is that stimulating cellular immunity is more important than producing antibodies, but some experts are now reviving the antibody strategy. By Erika Check, Nature's Washington biomedical correspondent. Nature 423, 912, 26 June 2003. Free full-text article.
APOBEC3G, a cellular protein that can inhibit HIV during reverse transcription, has been characterized
Three different groups have discovered how APOBEC3G obstructs HIV replication. Its effect can be countered by the HIV-1 virion infectivity factor (Vif). Cell 113, 803, 13 June 2003. See also Nature 424, 94, 3 July 2003, and Nature 424, 99, 3 July 2003.
VaxGen to complete phase III trial in Thailand
Vaccine developer VaxGen Inc. (Nasdaq: VXGN) issued a statement in response to several newspaper articles this week that inaccurately stated that the company was planning to withdraw from its Phase III trial in Thailand.
Progress reported in effort to create a mouse model for HIV
Researchers identified an important role for the splicing inhibitor hp32 in viral replication, which must be considered in the creation of the mouse model for HIV infection. Nature Cell Biology, published online 29 June 2003.
Latest News Headlines
[What is this?]
Africa forum tackles AIDS
Thailand: Campaign on condom use to get a push
HIV cocktail halves AIDS death rate, progression to full-blown disease
Politics slows agreement on lifesaving drugs
China, India face AIDS disaster
VaxGen to complete phase III trial in Thailand
U.S. FDA approves Emtricitabine
Is new HIV drug worth the expense?
U.K fertility clinics 'risking HIV spread'
Ex-Eli Lilly chief may be U.S. AIDS co-ordinator
VaxGen to stop funding of vaccine trial
Biosyn submits IND application for novel HIV microbicide
Scientist who took on smallpox finds a tougher nut to crack
Irish scientist discovers new strain of AIDS virus
HIV vaccines: where next?
CombiMatrix's siRNA compounds targeted against HIV will be tested
Race is on to save the first AIDS vaccine. But does it even work?
HIV/AIDS epidemic hits food output in Africa
Researchers work to infect mice with HIV
Brazil: AIDS and STD control III project
International trials for Norwood's AIDS research
Are needles spreading HIV?
Southern African leaders to hold AIDS summit
AIDS vaccine effort is urged
HIV find could help vaccine makers
Study links bisexuality to HIV spread among minority women
Minorities, heterosexuals tend to delay HIV test
Canada plans injection site for drug users
U.S. to distribute 250,000 quick AIDS tests
Doctors play key role in more HIV testing (opinion)
Trial of infant HIV vaccine to begin this fall
Canada sets sanctioned site to inject drugs
Additional FDA clearance for ViroSeq™ HIV-1 genotyping system
Agencies take HIV tests to public
Campaign seeks to make scientific reports available to public
AIDS funding is only half of what will be needed by 2005
Massachusetts: HIV rates stagnant in some age groups
Study: many gay, bisexual men report unsafe sex
AIDS fight grabs spotlight
Women are making a stand to raise awareness of AIDS
Transplants give life to HIV-infected
Blood test may predict HIV-related dementia
Laos opens up to world and AIDS threat
Genetic tests predict AIDS vulnerability
Testing time
U.K. calls for new HIV campaign
HIV/AIDS explosion in Russia triggers research boom
Preventing HIV (editorial)
VaxGen opens biopharmaceutical manufacturing facility
AIDS burdens Kenya prison warders
Fortress Britain at risk of disease
U.N. report adds to a condom debate
U.S. FDA approves first once-daily AIDS drug
HIV infects 3 percent of gays in Beijing
Leaders back away from AIDS pledge
HIV patients tapping into alternative medicine
Unsafe sex rates high in Miami Beach, Florida
More news headlines:
This week | Last week | Search archive
Latest Journal Headlines   [What is this?]
Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O. AIDS Research and Human Retroviruses.
Longitudinal study of humoral immune responses in HIV-1 subtype CRF01_AE (E)-infected Thai patients. AIDS Research and Human Retroviruses.
Global neutralization resistance phenotype of human immunodeficiency virus type 1. Journal of Virology.
Kunjin virus replicon vectors for human immunodeficiency virus vaccine development. Journal of Virology.
Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. Journal of Immunology.
The need for a global HIV vaccine enterprise. Science.
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science.
Enhanced T-cell immunogenicity of plasmid DNA vaccines/MVA boost in humans. Nature Medicine.
Characteristics of individuals with male-to-male and heterosexually acquired infectious syphilis. Sexually Transmitted Diseases.
Sexual transmission of HIV in Africa. Nature.
Viral infections among HIV-infected and high-risk HIV-uninfected women. Journal of Infectious Diseases.
Advancing HIV prevention: New strategies for a changing epidemic — United States, 2003. Morbidity and Mortality Weekly Report.
Rapid fingerstick testing: A new era in HIV diagnostics. AIDS Clinical Care.
HIV incidence among street youth in Montreal, Canada. AIDS.
The contribution of steady and casual partnerships to the incidence of HIV infection. AIDS.
Public policy regulating private and public space in gay bathhouses. Journal of Acquired Immune Deficiency Syndromes.
Rectal use of nonoxynol-9 among men who have sex with men. AIDS.
Risk factors for incident HIV infection among anonymous HIV testing site clients. Journal of Acquired Immune Deficiency Syndromes.
Incubation and duration of specific symptoms at ARS as independent predictors of progression to AIDS. Journal of Acquired Immune Deficiency Syndromes.
Voluntary HIV testing among inmates. Journal of Acquired Immune Deficiency Syndromes.
Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission. Journal of Acquired Immune Deficiency Syndromes.
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS.
Is breastfeeding best for HIV-positive mothers?. AIDS.
Chlamydophila pneumoniae and HIV-associated dementia complex. Journal of Neuroimmunology.
HIV-associated Guillain-Barre syndrome. Journal of the Neurologicals Sciences.
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood.
HIV-1 Tat can favor the establishment of neoplasia. Journal of Biological Chemistry.
Inhibition of human immunodeficiency virus type 1 env-mediated fusion by DC-SIGN. Journal of Virology.
Increased in vitro cytopathicity of R5/NSI HIV-1 correlates with a progressive course of infection. Journal of Infectious Diseases.
Decreased stimulation of CD4+ T cell proliferation and IL-2 production by infected dendritic cells. Journal of Immunology.
Review: AIDS pathogenesis: what have two decades of HIV research taught us?. Nature Reviews Immunology.
Natural variation of the nef gene in human immunodeficiency virus type 2 infections in Portugal. Journal of General Virology.
Clade B HIV-1 superinfection with wild-type virus after primary infection. AIDS.
Serum immunoglobulin A (IgA)-mediated immunity in HIV-2 infection. Virology.
The functional relationship between V3 loop and gp120 context with regard to HIV coreceptor usage. Virology.
In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes. Virology.
Transmission of HIV-1 infection between trophoblast placental cells and T-cells. Virology.
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV. Proc. Natl. Acad. Sci. USA.
Innate immunity in HIV infection: Effect of viremia on natural killer cell function. Journal of Infectious Diseases.
Microanatomic relationships between CD8+ cells and HIV-1-producing cells in human lymphoid tissue. Journal of Acquired Immune Deficiency Syndromes.
Bystander CD4(+) T lymphocytes survive in HIV-infected human lymphoid tissue. AIDS Research and Human Retroviruses.
Enhanced transcytosis of R5 HIV across tight monolayer of polarized human endometrial cells. Cytokine.
A more accurate assessment of HIV-1 replication dynamics and T-cell decay in vivo. Journal of Virology.
Latent viral reservoir in a SIV-Macaca nemestrina model of HIV-1-infected patients on HAART. Journal of Virology.

More news headlines:  This month | Last month | Search archive
This Week's Researchers [What is this?]



Privacy Policy     Site Map    
Published by the American Association for the Advancement of Science.

Copyright © 2003 by the American Association for the Advancement of Science.